Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
All LSBio Custom kits have been predesigned and all necessary components, including antibodies and standards have been identified. Upon receiving a custom kit order, the kit will be assembled and quality control tested before being shipped out. Kit assembly and testing typically takes 4 to 6 weeks. In most cases the final kit is based on the Sandwich assay principle, with a few being Competitive EIA based. Specifications such as Range, Sensitivity, and Precision are defined upon completion. In the event that the custom kit cannot be successfully developed with 6 weeks of the order date, the customer will be notified and the order canceled at no cost.
F9 / Factor IX
LS-F15325 is a 96-well enzyme-linked immunosorbent assay (ELISA) for the detection of Pig F9 / Factor IX. It is based upon a Custom assay principle.
F9 ElisaKit, Christmas Disease ElisaKit, Coagulation factor IX ElisaKit, Factor IX Deficiency ElisaKit, FIX ElisaKit, HEMB ElisaKit, F9 p22 ElisaKit, Factor 9 ElisaKit, Factor IX ElisaKit, Factor IX F9 ElisaKit, FIX F9 ElisaKit, Haemophilia B ElisaKit, THPH8 ElisaKit, Christmas factor ElisaKit, Hemophilia B ElisaKit, PTC ElisaKit, Serine protease ElisaKit
F9 / Factor IX is a vitamin K-dependent coagulation factor IX that circulates in the blood as an inactive zymogen. This factor is converted to an active form by factor XIa, which excises the activation peptide and thus generates a heavy chain and a light chain held together by one or more disulfide bonds. The role of this activated factor IX in the blood coagulation cascade is to activate factor X to its active form through interactions with Ca+2 ions, membrane phospholipids, and factor VIII.